Moreover, they found that concentrations of TACSTD2 in urinary exosomes had 6.5-fold higher expression in bladder cancer patients compared to control patients, which has high potential as a novel biomarker for early diagnosis and prognosis for bladder cancer. Here, TACSTD2 is linked to urinary bladder carcinoma.